Myocardial infarction during giant cell arteritis: A cohort study

Salvarani, 2002, Polymyalgia rheumatica and giant-cell arteritis, N Engl J Med, 347, 261, 10.1056/NEJMra011913 Hunder, 1990, The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum, 33, 1122, 10.1002/art.1780330810 Richier, 2020, Giant cell arteritis incidence in La Reunion island, a particularly cosmopolite region of south hemisphere, Eur J Intern Med, 74, 119, 10.1016/j.ejim.2020.01.019 Weyand, 2003, Medium- and large-vessel vasculitis, N Engl J Med, 349, 160, 10.1056/NEJMra022694 de Boysson, 2017, Giant cell arteritis-related stroke: a retrospective multicenter case-control study, J Rheumatol, 44, 297, 10.3899/jrheum.161033 Samson, 2015, Stroke associated with giant cell arteritis: a population-based study, J Neurol, Neurosurg Psychiatry, 86, 216, 10.1136/jnnp-2014-307614 Caudrelier, 2019, Validation of giant cell arteritis diagnosis code in the French hospital electronic database, Eur J Intern Med, 60, e16, 10.1016/j.ejim.2018.10.004 Weyand, 2013, Immune mechanisms in medium and large-vessel vasculitis, Nat Rev Rheumatol, 9, 731, 10.1038/nrrheum.2013.161 Watanabe, 2017, Immune checkpoint dysfunction in large and medium vessel vasculitis, Am J Physiol Heart Circ Physiol, 312, H1052, 10.1152/ajpheart.00024.2017 Proven, 2003, Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes, Arthr Rheum, 49, 703, 10.1002/art.11388 Samson, 2018, Tocilizumab as an add-on therapy to glucocorticoids during the first 3months of treatment of Giant cell arteritis: A prospective study, Eur J Intern Med, 10.1016/j.ejim.2018.06.008 Samson, 2018, Biological treatments in giant cell arteritis & Takayasu arteritis, Eur J Intern Med, 50, 12, 10.1016/j.ejim.2017.11.003 Mahr, 2007, Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis, Arthr Rheum, 56, 2789, 10.1002/art.22754 Stone, 2017, Trial of Tocilizumab in Giant-Cell Arteritis, N Engl J Med, 377, 317, 10.1056/NEJMoa1613849 Thygesen, 2018, Fourth universal definition of myocardial infarction, Circulation, 138, e618, 10.1161/CIR.0000000000000617 Saaby, 2013, Classification of myocardial infarction: frequency and features of type 2 myocardial infarction, Am J Med, 126, 789, 10.1016/j.amjmed.2013.02.029 Thygesen, 2012, Third universal definition of myocardial infarction, Circulation, 126, 2020, 10.1161/CIR.0b013e31826e1058 Landes, 2016, Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction, J Cardiol, 67, 51, 10.1016/j.jjcc.2015.04.001 Putot, 2020, Type 2 myocardial infarction: a geriatric population-based model of pathogenesis, Aging Dis, 11, 108, 10.14336/AD.2019.0405 Landesberg, 2009, Perioperative myocardial infarction, Circulation, 119, 2936, 10.1161/CIRCULATIONAHA.108.828228 Gupta, 2017, Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies, Cardiovasc Diagn Ther, 7, 348, 10.21037/cdt.2017.03.21 Kermani, 2018, Prognosis and monitoring of giant cell arteritis and associated complications, Expert Rev Clin Immunol, 14, 379, 10.1080/1744666X.2018.1467758 Robson, 2015, The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK, Ann Rheum Dis, 74, 129, 10.1136/annrheumdis-2013-204113 Schönau, 2018, The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study, Ann Rheum Dis, 77, 70, 10.1136/annrheumdis-2017-211687 Prieto-Gonzalez, 2014, Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study, Ann Rheum Dis, 73, 1388, 10.1136/annrheumdis-2013-204572 Kermani, 2013, Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis, Ann Rheum Dis, 72, 1989, 10.1136/annrheumdis-2012-202408 Blockmans, 2006, Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients, Arthr Rheum, 55, 131, 10.1002/art.21699 Ghinoi, 2012, Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study, Rheumatology (Oxford), 51, 730, 10.1093/rheumatology/ker329 Le Page, 2006, Incidence of cardiovascular events in giant cell arteritis: preliminary results of a prospective double cohort study (GRACG), Rev Med Interne, 27, 98, 10.1016/j.revmed.2005.10.009 Ray, 2005, Giant cell arteritis and cardiovascular disease in older adults, Heart, 91, 324, 10.1136/hrt.2004.037481 Tomasson, 2014, Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study, Ann Intern Med, 160, 73, 10.7326/M12-3046 Pariente, 2019, Ischemic stroke in giant-cell arteritis: French retrospective study, J Autoimmun, 99, 48, 10.1016/j.jaut.2019.01.009 Gonzalez-Gay, 2009, Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis, Medicine (Baltimore), 88, 227, 10.1097/MD.0b013e3181af4518 Amiri, 2016, Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study, Rheumatology (Oxford), 55, 33, 10.1093/rheumatology/kev262 Li, 2017, Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink, Rheumatology (Oxford), 56, 753 Lin, 2007, Myocardial infarction due to giant cell arteritis: a case report and literature review, Kaohsiung J Med Sci, 23, 195, 10.1016/S1607-551X(09)70397-3 Salvarani, 2008, Polymyalgia rheumatica and giant-cell arteritis, Lancet, 372, 234, 10.1016/S0140-6736(08)61077-6 Zeller, 2008, Relation between body mass index, waist circumference, and death after acute myocardial infarction, Circulation, 118, 482, 10.1161/CIRCULATIONAHA.107.753483 Granger, 2003, Predictors of hospital mortality in the global registry of acute coronary events, Arch Intern Med, 163, 2345, 10.1001/archinte.163.19.2345 Cerqueira Junior, 2018, Prognostic Accuracy of the GRACE Score in Octogenarians and Nonagenarians with Acute Coronary Syndromes, Arq Bras Cardiol, 110, 24 Pepine, 2015, Emergence of nonobstructive coronary artery disease: a woman's problem and need for change in definition on angiography, J Am Coll Cardiol, 66, 1918, 10.1016/j.jacc.2015.08.876 Ammann, 2001, Elevation of troponin I in sepsis and septic shock, Intensive Care Med, 27, 965, 10.1007/s001340100920 Putot, 2019, Type 1 or Type 2 myocardial infarction in patients with a history of coronary artery disease: data from the emergency department, J Clin Med, 8, 10.3390/jcm8122100 Avina-Zubieta, 2013, Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study, Rheumatology (Oxford), 52, 68, 10.1093/rheumatology/kes353 Wilson, 2017, Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): a nested case-control analysis, Semin Arthr Rheum, 46, 819, 10.1016/j.semarthrit.2016.11.006 Wei, 2004, Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease, Ann Intern Med, 141, 764, 10.7326/0003-4819-141-10-200411160-00007 Borchers, 2012, Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment, Autoimmun Rev, 11, A544, 10.1016/j.autrev.2012.01.003 Muratore, 2015, Large-vessel giant cell arteritis: a cohort study, Rheumatology (Oxford), 54, 463, 10.1093/rheumatology/keu329